This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Academic Highlights

The Roadmap for Antipsychotic Psychopharmacology: An Overview

Peter J. Weiden, M.D.; Sheldon H. Preskorn, M.D.; Peter A. Fahnestock, M.D.; Daniel Carpenter, Ph.D.; Ruth Ross, M.A.; and John P. Docherty, M.D.

Published: November 15, 2007

Article Abstract

Click to enlarge page

This article summarizes recommendations from a recently published supplement, Translating the Psychopharmacology of Antipsychotics to Individualized Treatment for Severe Mental Illness: A Roadmap. The President’s New Freedom Commission on Mental Health stressed the importance of incorporating the latest scientific information into mainstream health care as rapidly as possible. In keeping with this goal, the Roadmap drew on clinical trial data, information on antipsychotic pharmacology, practice guidelines, consensus statements, and expert opinion to develop recommendations for achieving best outcomes for individual patients.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 68

Quick Links: